[Lupus erythematosus and synthetic antimalarials: personal experience with nivaquine, its advantages over quinacrine, in 41 cases].
D000962:Antimalarials; D002738:Chloroquine; D008180:Lupus Erythematosus, Systemic / Q000628:therapy*; D011796:Quinacrine / Q000627:therapeutic use*; D011804:Quinolines / Q000627:therapeutic use*; D014528:Uricosuric Agents
D000962:Antimalarials; D011804:Quinolines; D014528:Uricosuric Agents; D002738:Chloroquine; D011796:Quinacrine
LUPUS ERYTHEMATOSUS/therapy; QUINACRINE/therapeutic use; QUINOLINES/therapeutic use
Lupus érythémateux et anti-paludique de synthèse; expérience personnelle avec la nivaquine, ses avantages sur la quinacrine, à propos de 41 cas.